What best describes the pathophysiology of cancer during chemotherapy or radiotherapy?

What best describes the pathophysiology of cancer during chemotherapy or radiotherapy?

• A. Cytotoxic treatments impair cellular function, cause fatigue, anaemia, and immunosuppression.
• B. Cancer cells become more differentiated and less aggressive.
• C. Treatment enhances immune function leading to reduced infection risk.
• D. There is no systemic impact on the patient.

Answer: (A)

The main idea is that chemotherapy and radiotherapy are cytotoxic treatments that don’t target cancer cells perfectly; they damage rapidly dividing cells throughout the body. This leads to systemic effects such as fatigue from overall energy loss, anemia from bone marrow suppression, and immunosuppression from reduced white blood cell counts. These toxicities reflect the non-selective nature of these therapies and the broader impact on normal tissues that divide quickly, like bone marrow and mucosal lining. While cancer cells may die or respond to treatment, the hallmark pathophysiology during these therapies is non-specific cellular damage causing systemic toxicity. The other statements don’t fit: treatment doesn’t generally make cancer cells more differentiated or less aggressive as a universal outcome, it doesn’t typically enhance immune function (often it suppresses it), and there is indeed a systemic impact rather than none at all.

The main idea is that chemotherapy and radiotherapy are cytotoxic treatments that don’t target cancer cells perfectly; they damage rapidly dividing cells throughout the body. This leads to systemic effects such as fatigue from overall energy loss, anemia from bone marrow suppression, and immunosuppression from reduced white blood cell counts. These toxicities reflect the non-selective nature of these therapies and the broader impact on normal tissues that divide quickly, like bone marrow and mucosal lining. While cancer cells may die or respond to treatment, the hallmark pathophysiology during these therapies is non-specific cellular damage causing systemic toxicity. The other statements don’t fit: treatment doesn’t generally make cancer cells more differentiated or less aggressive as a universal outcome, it doesn’t typically enhance immune function (often it suppresses it), and there is indeed a systemic impact rather than none at all.